Ubie and Nucleus Genomics Partner to Enhance Genetic Testing Access and Early Screening

Feb 27, 2025•5 months ago

Contract Type

partnership

JapanMedicalArtificial IntelligenceBiotechnologyHealth Care

Description

Ubie has partnered with Nucleus Genomics to improve access to genetic testing and promote early screening for better health outcomes. This partnership aims to revolutionize the healthcare industry by leveraging advanced genetic technologies.

Company Information

Company

Ubie

Location

Japan

About

Ubie is a Japanese health-tech startup founded by a medical doctor and an engineer in 2017. Using AI as its core technology, the company develops and provides an AI-powered patient questionnaire that guides patients from symptoms to appropriate medical care and improves operational efficiency in the medical field. Ubie is promoting the creation of a society in which anyone can access medical care that suits them best. For more information, please visit: http://company.ubiehealth.comAI-powered symptom checker: https://ubiehealth.com(Japanese version: https://ubie.app/ ) View original content:https://www.prnewswire.com/news-releases/ubie-japanese-health-tech-startup-raises-26-2-million-in-series-c-59-8-million-in-total-301609676.html

Agreement Insights

Based on industry data

Strategic partnership established

Partnership agreements typically involve technology integration and joint go-to-market strategies

Contract momentum indicator

Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Ubie and Nucleus Genomics Partner to Enhance Genetic Testing Access and Early Screening

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Agreement Insights

Company Information